Barclays Maintains Overweight on Baxter Intl, Lowers Price Target to $54
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Matt Miksic has maintained an Overweight rating on Baxter Intl (NYSE:BAX) but lowered the price target from $58 to $54.
July 31, 2023 | 10:08 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays has maintained an Overweight rating on Baxter Intl but lowered the price target from $58 to $54.
The news is directly related to Baxter Intl as Barclays has maintained an Overweight rating but lowered the price target. This could indicate that Barclays sees potential in the company but is adjusting expectations due to market conditions. The impact on the stock price is neutral in the short term as the positive of maintaining the Overweight rating is balanced by the negative of lowering the price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100